$CODX Up 22% Premarket 🚀 🔹 Co-Diagnostics gaining traction as molecular diagnostics names heat up 📈 🔹 Company develops PCR-based testing tech for infectious

$CODX Up 22% Premarket 🚀 🔹 Co-Diagnostics gaining traction as molecular diagnostics names heat up 📈 🔹 Company develops PCR-based testing tech for infectious disease, liquid biopsy & other nucleic acid detection markets 🧬 🔹 Recent focus remains on its Co-Dx PCR platform, India TB studies & Sout…